Read all posts
failover.medpagetoday.com

High-Dose Omega-3s May Lower AD Risk in APOE4 Carriers

Read the article on

Dr. Sears Comments:

Dr. Barry Sears
Alzheimer’s is an inflammatory disease.  The only way to resolve inflammation is by increasing the resolution response that generated by resolvins that come from omega-3 fatty acids.  To get adequate levels in the brain, requires adequate levels in the blood.  The omega-3 fatty acids (both EPA and DHA) enter the brain via transport mechanism mediated by ApoE.  Those with ApoE4 mutant will simply  require more EPA and DHA in the blood to get enough into the brain to resolve the inflammation that causes Alzheimer’s.  I don’t consider the levels that they used to be high-dose, instead I would call just above placebo-dose

Leave a Reply

Your email address will not be published. Required fields are marked *